HORMONE-REFRACTORY PROSTATE CANCER

This adverse event was reported 1188 times

These drugs are most commonly taken by patients reporting HORMONE-REFRACTORY PROSTATE CANCER:

# Drug Count
0 RADIUM RA 223 DICHLORIDE 436
1 DOCETAXEL 196
2 DOCETAXEL ANHYDROUS 196
3 ENZALUTAMIDE 182
4 LEUPROLIDE ACETATE 174
5 LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN 167
6 ABIRATERONE ACETATE 152
7 ABIRATERONE 114
8 BICALUTAMIDE 101
9 PREDNISONE 88
See all common drugs associated with HORMONE-REFRACTORY PROSTATE CANCER

HORMONE-REFRACTORY PROSTATE CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RADIUM RA 223 DICHLORIDE 436 0.0863
1 CABAZITAXEL 79 0.0225
2 FLUTAMIDE 12 0.0121
3 LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN 167 0.0121
4 BICALUTAMIDE 101 0.0066
5 DEGARELIX 24 0.0045
6 ABIRATERONE ACETATE 152 0.0037
7 ENZALUTAMIDE 182 0.0031
8 DOCETAXEL 196 0.0029
9 DOCETAXEL ANHYDROUS 196 0.0029
See all drugs enriched for association with HORMONE-REFRACTORY PROSTATE CANCER